Latest Regulatory News

Page 647 of 744
Little Green Pharma reported a robust 40% revenue increase for FY25, driven by strong European sales and the strategic acquisition of Health House. The company also advanced clinical research and secured new therapy funding, positioning itself for continued growth.
Ada Torres
Ada Torres
30 Apr 2025
Boab Metals has inked a A$10 million deal to acquire the DeGrussa Processing Plant from Sandfire Resources, significantly derisking and reducing upfront capital costs for its Sorby Hills Project. Completion hinges on a final investment decision expected in the second half of 2025.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Tissue Repair Limited reports progress in its Phase 3 clinical trials for TR987® despite enrollment delays caused by US regulatory disruptions, while TR Pro+® sales hit record highs and manufacturing scale-up advances.
Ada Torres
Ada Torres
30 Apr 2025
Argent BioPharma reports significant operational savings through manufacturing outsourcing, encouraging Phase IIb results for CimetrA®, and key regulatory approvals for cannabinoid therapies in Germany.
Ada Torres
Ada Torres
30 Apr 2025
EV Resources Limited advances its position in the critical antimony market with a 70% stake acquisition in Mexico’s Los Lirios project and full ownership of Utah’s historic Coyote Creek claims, setting the stage for exploration and development.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Golden Mile Resources is set to commence its maiden drilling program at the Pearl Copper Project in Arizona, following significant gold and silver assays at the newly identified Aurora Prospect. The company has secured key federal permits, marking a pivotal step in its US exploration campaign.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Starpharma reports steady progress in its DEP® drug development programs, launches new marketing campaigns in key regions, and maintains a strong cash position of $17.2 million as it refines clinical strategies and partnerships.
Ada Torres
Ada Torres
30 Apr 2025
Constellation Technologies Limited reports sustained sales growth and positive cash flow in Q3 2025, driven by its Callisto Food Safety & Compliance system and strategic market expansion.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Alterity Therapeutics reports compelling Phase 2 clinical trial results for ATH434 in Multiple System Atrophy, alongside a significant capital raise strengthening its financial position for upcoming regulatory milestones.
Ada Torres
Ada Torres
30 Apr 2025
Kingsrose Mining advances its Fennoscandian exploration with high-grade discoveries and strategic acquisition of the Jakon project, supported by robust funding from BHP.
Maxwell Dee
Maxwell Dee
30 Apr 2025
RBR Group Limited has signed a conditional MOU with Field Ready Group to establish a joint venture focused on employability training in Mozambique, supporting major LNG projects including ExxonMobil’s Rovuma LNG. The venture, through RBR’s subsidiary Futuro Skills, aims to enhance local workforce readiness and economic growth.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Genesis Resources has completed its acquisition of full ownership of the Plavica JV in North Macedonia and is progressing environmental studies and exploration planning for multiple Australian tenements ahead of 2025 drilling campaigns.
Maxwell Dee
Maxwell Dee
30 Apr 2025